MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study

A. Velon, M. Mendes, R. Raimundo, R. Jesus, R. Almendra (Vila Real, Portugal)

Meeting: 2018 International Congress

Abstract Number: 1727

Keywords: Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: Determine and compare vascular risk factors between VaP and PD patients in a hospital-based sample.

Background: Most studies demonstrate that vascular risk factors are more frequent in VaP than PD patients. Nonetheless dyslipidaemia and obesity haven´t been well studied.

Methods: We analysed 50 patients (VaP: 16 and PD: 34) observed in our movement disorder outpatient department since 2015. Vascular risk factors were determined considering past medical history interview, patient hospital files and drug history. In the same visit body mass index, arterial pressure and cardiac rate were evaluated. We considered the following vascular risk factors: hypertension, diabetes, hyperlipidaemia, atrial fibrillation, anticoagulation, ischemic cardiac conditions, cerebrovascular disease and obesity (BMI ≥ 30).

Results: Fifty patient were evaluated with a mean age of 72,36 years (standard deviation, SD: 9,19), 54% were male. Mean body mass index was 26,91 (SD: 3,93) in VaP patients and 27,51 (SD: 3,54) in PD patients. Using chi-squared test, VP patients had statistically more dyslipidaemia (p=. 004) than DP patients. The remainder vascular risk factors were equally distributed between the two disease groups.

Conclusions: Vascular risk factors distribution wasn´t different between VaP and PD patients in our sample, except for dyslipidaemia, which was more frequent in VaP group.

To cite this abstract in AMA style:

A. Velon, M. Mendes, R. Raimundo, R. Jesus, R. Almendra. Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/vascular-risk-factors-prevalence-differences-between-vascular-parkinsonism-vap-and-parkinson-disease-pd-in-a-hospital-cross-section-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/vascular-risk-factors-prevalence-differences-between-vascular-parkinsonism-vap-and-parkinson-disease-pd-in-a-hospital-cross-section-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley